Referências
Principais artigos
Franchini M, Lippi G, Manzato F. Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation. Thromb J. 2006 Feb 21;4:4.Texto completo Resumo
Taylor FB Jr, Toh CH, Hoots WK, et al; Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society of Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001 Nov;86(5):1327-30. Resumo
Levi M, Toh CH, Thachil J, et al. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol. 2009 Apr;145(1):24-33.Texto completo Resumo
Artigos de referência
1. Levi M, De Jonge E, van der Poll T. New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology. Ann Med. 2004;36(1):41-9. Resumo
2. Franchini M, Lippi G, Manzato F. Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation. Thromb J. 2006 Feb 21;4:4.Texto completo Resumo
3. Asakura H, Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol. 2021 Jan;113(1):45-57.Texto completo Resumo
4. Taylor FB Jr, Toh CH, Hoots WK, et al; Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society of Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001 Nov;86(5):1327-30. Resumo
5. Gando S, Nakanishi Y, Tedo I. Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome. Crit Care Med. 1995 Nov;23(11):1835-42. Resumo
6. Asakura H, Takahashi H, Uchiyama T, et al. Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J. 2016 Sep 28;14:42.Texto completo Resumo
7. Levi M, Scully M. How I treat disseminated intravascular coagulation. Blood. 2018 Feb 22;131(8):845-54.Texto completo Resumo
8. Papageorgiou C, Jourdi G, Adjambri E, et al. Disseminated intravascular coagulation: an update on pathogenesis, diagnosis, and therapeutic strategies. Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):8S-28S.Texto completo Resumo
9. Costello RA, Nehring SM. Disseminated intravascular coagulation (DIC). StatPearls [Internet]. 2019 Nov 30.Texto completo Resumo
10. Levi M, Toh CH, Thachil J, et al. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol. 2009 Apr;145(1):24-33.Texto completo Resumo
11. Walborn A, Hoppensteadt D, Syed D, et al. Biomarker profile of sepsis-associated coagulopathy using biochip assay for inflammatory cytokines. Clin Appl Thromb Hemost. 2018 May;24(4):625-32.Texto completo Resumo
12. Greenberg CS. The role of D-dimer testing in clinical hematology and oncology. Clin Adv Hematol Oncol. 2017 Aug;15(8):580-3. Resumo
13. Xu Y, Zhu R, Sun Y, et al. Antithrombin III for early diagnosis of DIC in sepsis patients: a retrospective analysis with 445 patients [in Chinese]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017 Feb;29(2):127-32. Resumo
14. Chernecky CC, Berger BJ. Fibrinopeptide A. (FPA)-blood. In: Chernecky CC, Berger BJ, eds. Laboratory tests and diagnostic procedures. 6th ed. St Louis, MO: Elsevier Saunders; 2013:526-7.
15. Ota S, Wada H, Abe Y, et al. Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis. Clin Appl Thromb Hemost. 2008 Jul;14(3):279-85.Texto completo Resumo
16. Lemmer JH Jr, Despotis GJ. Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2002 Feb;123(2):213-7.Texto completo Resumo
17. Avvisati G, ten Cate JW, Buller HR, et al. Tranexamic acid for control of hemorrhage in acute promyelocytic leukemia. Lancet. 1989 Jul 15;2(8655):122-4. Resumo
18. Hagiwara A, Tanaka N, Uemura T, et al. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial. BMJ Open. 2016 Dec 30;6(12):e012850.Texto completo Resumo
19. Yasuda N, Goto K, Ohchi Y, et al. The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation. J Crit Care. 2016 Dec;36:29-34. Resumo
20. Franchini M, Manzato F, Salvagno GL, et al. Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review. Blood Coagul Fibrinolysis. 2007 Oct;18(7):589-93. Resumo
21. Moscardo F, Perez F, de la Rubia J, et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol. 2001 Jul;114(1):174-6. Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal